Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
EvolveImmune Therapeutics Inc in Branford, CT is seeking a Principal Scientist to join our Translational Sciences team to design and advance first-in-class immune-engaging biologics for cancer.
This hands-on, lab-based role drives IND enabling studies and early clinical programs, with collaboration across Immunobiology, Biotherapeutics and Translational Sciences to translate preclinical findings into human therapies.
EvolveImmune Therapeutics is a privately-held, next-generation immuno-oncology company pioneering a new class of T cell engager therapies to transform cancer patient outcomes compared to current immunotherapies. Our first-in-category biotherapeutic EVOLVE platform utilizes integrated T cell costimulation to directly target tumor cells to deliver durable anti-tumor adaptive immune responses. Our lead asset, EVOLVE104, entered clinical trials in late 2025. Additional collaboration pipeline programs (with Abbvie) and wholly owned programs are progressing toward candidate nomination. EvolveImmune’s team consists of ~50 FTEs in R&D, business development, people & culture, finance and operations. Our newly expanded, state-of-the-art 20,000+ square foot laboratory and office space located in the New Haven, CT biotechnology corridor is convenient to the amenities of the Connecticut shoreline, the city of New Haven and easy travel options throughout the Boston/New York City corridor.
We’re hiring a Principal Scientist to join our collaborative Translational Sciences team focused on designing and advancing first-in-class immune-engaging biologics. This is a hands-on, lab-based role where your contributions directly shape the next generation of immunotherapy.
We value curiosity, collaboration, and diverse perspectives—if you’re excited by our mission but unsure if you meet every requirement, we encourage you to apply.
In this role you will execute translational immunology research to support IND enabling activities and phase I clinical studies in oncology. Experience in immune-assay development and expertise in human immunology and T cell immunobiology are required. The role involves experimental design (CRO and internal) and execution (bench work) as well as interpretation and presentation of results. This is an exciting opportunity for a highly collaborative and creative scientist who is eager to position novel immunotherapies in the cancer immunology treatment landscape. Close collaboration and matrix working with members of the Immunobiology, Biotherapeutics and Translational Sciences teams are expected. Evidence for a track record of scientific and/or project achievements is preferred.